Correlation Between Neutra Corp and Nanobac Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neutra Corp and Nanobac Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neutra Corp and Nanobac Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neutra Corp and Nanobac Pharmaceuticals Incorporated, you can compare the effects of market volatilities on Neutra Corp and Nanobac Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neutra Corp with a short position of Nanobac Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neutra Corp and Nanobac Pharmaceuticals.

Diversification Opportunities for Neutra Corp and Nanobac Pharmaceuticals

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Neutra and Nanobac is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neutra Corp and Nanobac Pharmaceuticals Incorp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanobac Pharmaceuticals and Neutra Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neutra Corp are associated (or correlated) with Nanobac Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanobac Pharmaceuticals has no effect on the direction of Neutra Corp i.e., Neutra Corp and Nanobac Pharmaceuticals go up and down completely randomly.

Pair Corralation between Neutra Corp and Nanobac Pharmaceuticals

If you would invest  0.02  in Neutra Corp on September 3, 2024 and sell it today you would lose (0.01) from holding Neutra Corp or give up 50.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Neutra Corp  vs.  Nanobac Pharmaceuticals Incorp

 Performance 
       Timeline  
Neutra Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Neutra Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Neutra Corp reported solid returns over the last few months and may actually be approaching a breakup point.
Nanobac Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nanobac Pharmaceuticals Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Nanobac Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Neutra Corp and Nanobac Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neutra Corp and Nanobac Pharmaceuticals

The main advantage of trading using opposite Neutra Corp and Nanobac Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neutra Corp position performs unexpectedly, Nanobac Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanobac Pharmaceuticals will offset losses from the drop in Nanobac Pharmaceuticals' long position.
The idea behind Neutra Corp and Nanobac Pharmaceuticals Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Transaction History
View history of all your transactions and understand their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like